PACT

The mark consists of the word "PACT" with the the letter "T" being split vertically.

Mark For: PACT® trademark registration is intended to cover the categories of development of pharmaceuticals comprising personalized adoptive cell therapies; development of pharmaceuticals comprising adoptive cell therapies; analysis of neoepitopes; design of personalized adoptive cell therapies; detection of truncal cancer mutations in patient tumor cells; consultation pertaining to adoptive cell therapies; developing personal treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; pharmaceutical development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceuticals for the treatment of cancer and oncological conditions; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; collection of molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals. [all]

>Color is not claimed as a feature of the mark. The mark consists of the word "PACT" with the the letter "T" being split vertically.

Status

2020-01-18 UTC
⟳ Refresh

LIVE APPLICATION Awaiting Examination

Research	OneLook Acronym Finder
Serial Number	88686155
Registration Number	6451316
Mark Literal Elements	PACT
Mark Drawing Type	5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM
Mark Type	SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	NEW APPLICATION PROCESSING 2019-11-16
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Cara R. Baer
Attorney Docket Number	50180.202084

Timeline

IC 042. US 100 101. G & S: development of pharmaceuticals comprising personalized adoptive cell therapies; development of pharmaceuticals comprising adoptive cell therapies; analysis of neoepitopes; design of personalized adoptive cell therapies; detection of truncal cancer mutations in patient tumor cells; consultation pertaining to adoptive cell therapies; developing personal treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; pharmaceutical development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceuticals for the treatment of cancer and oncological conditions; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; collection of molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals. FIRST USE: 20170501. FIRST USE IN COMMERCE: 20170501